Invest now
Aurobindo Pharma Profit & Loss Annual
BSE: - | NSE: - | ISIN: - | Sector: -1,570.90 +10.35 (0.66%)Updated : 21 Jul 2026
Research on
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Operating Expense | 28,640.80 | 26,767.65 | 24,871.40 | 22,341.74 |
| Other Net | 492.09 | 215.00 | 184.10 | 117.31 |
| Diluted Weighted Average Shares | 58.08 | 58.29 | 58.59 | 58.59 |
| Depreciation/ Amortization | 1,778.19 | 1,633.97 | 1,491.91 | 1,244.58 |
| Operating Income | 5,012.28 | 4,956.08 | 4,130.47 | 2,513.64 |
| Net Income | 3,504.75 | 3,485.89 | 3,172.97 | 1,927.50 |
| Income Availableto Com Excl Extra Ord | 3,504.75 | 3,485.88 | 3,172.97 | 1,927.50 |
| Other Operating Expenses Total | 8,118.75 | 564.01 | 530.61 | 518.34 |
| Net Income Before Taxes | 5,111.85 | 5,066.29 | 4,379.99 | 2,612.50 |
| Minority Interest | 1.78 | 2.32 | 4.00 | -0.15 |
| Net Income After Taxes | 3,502.97 | 3,483.57 | 3,168.97 | 1,927.65 |
| Income Availableto Com Incl Extra Ord | 3,504.75 | 3,485.88 | 3,172.97 | 1,927.50 |
| Costof Revenue Total | 13,488.36 | 14,316.16 | 13,660.15 | 12,325.90 |
| Gross Profit | 20,164.72 | 17,407.57 | 15,341.72 | 12,529.48 |
| Interest Inc( Exp) Net- Non- Op Total | -392.52 | -104.79 | 41.93 | -31.68 |
| Unusual Expense( Income) | 65.33 | 26.87 | 254.23 | 23.96 |
| Diluted Net Income | 3,504.75 | 3,485.88 | 3,172.97 | 1,927.50 |
| Provisionfor Income Taxes | 1,608.88 | 1,582.72 | 1,211.02 | 684.85 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 3,504.75 | 3,485.89 | 3,172.97 | 1,927.50 |
| Total Revenue | 33,653.08 | 31,723.73 | 29,001.87 | 24,855.38 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 33,653.08 | 31,723.73 | 29,001.87 | 24,855.38 |
| Selling/ General/ Admin Expenses Total | 5,190.17 | 10,131.54 | 8,858.87 | 8,189.45 |
| Diluted Normalized EPS | 61.11 | 60.12 | 57.00 | 33.03 |
| Diluted EPS Excluding Extra Ord Items | 60.34 | 59.81 | 54.15 | 32.90 |
| Total Adjustmentsto Net Income | - | -0.10 | - | - |
| Gain( Loss)on Saleof Assets | - | 0.00 | 23.49 | 13.23 |
| DPS- Common Stock Primary Issue | - | 0.00 | 4.50 | 3.00 |
| Research Development | - | 95.10 | 75.63 | 39.51 |
*All figures in crores except per share values
Aurobindo Pharma Quick Links
Aurobindo Pharma Dividend Aurobindo Pharma Bonus Aurobindo Pharma News Aurobindo Pharma AGM Aurobindo Pharma Rights Aurobindo Pharma Splits Aurobindo Pharma Board Meetings Aurobindo Pharma Key Metrics Aurobindo Pharma Shareholdings Aurobindo Pharma Balance Sheet Aurobindo Pharma Cashflow Aurobindo Pharma Q1 Results Aurobindo Pharma Q2 Results Aurobindo Pharma Q3 Results Aurobindo Pharma Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
1,570.50+59.15(3.91%)
389.85+12.70(3.37%)
2,268.25+66.45(3.02%)
1,933.10-16.90 (-0.87%)
2,840.00-19.55 (-0.68%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.